VIRAL INTERLEUKIN-10 IS CRITICAL FOR THE INDUCTION OF B-CELL GROWTH TRANSFORMATION BY EPSTEIN-BARR-VIRUS

被引:129
作者
MIYAZAKI, I
CHEUNG, RK
DOSCH, HM
机构
[1] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT PEDIAT,DIV IMMUNOL & CANC,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT IMMUNOL,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1084/jem.178.2.439
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have used an efficient cDNA subtraction library procedure to identify newly induced genes in human B lymphocytes infected for 6 h with Epstein-Barr virus (EBV). Among the genes identified by automated sequencing of a random subset of clones from this library, one coded the EBV BCRF1 open reading frame, which specifies the viral interleukin 10 gene (vIL-10). This molecule is highly homologous to human (h)IL-10 and was previously thought to represent a ''late'' viral gene expressed only during the lytic phase of virus replication. Using gene amplification by reverse transcriptase polymerase chain reaction of B cell RNA obtained at varying times after infection, we detected vIL-10 expression within a few hours of EBV infection, followed, 20-30 h later by expression of hIL-10. Expression of both genes continued beyond the initial transformation phase (5-10 d) and was present in all transformed cell lines tested. When added at the time of viral infection, antisense (but not sense) oligonucleotides for vIL-10 mRNA (cytosolic half-life, approximately 6 h) prevented subsequent B cell transformation. The antisense effect was highly specific, leaving the expression levels of other transformation-related genes intact. Addition of exogenous (h)IL-10 rescued the transformation process in antisense-treated cells. Our observations establish vIL-10 as a new latency gene with a directly transformation-prerequisite function.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
[1]   EARLY EVENTS IN EPSTEIN-BARR-VIRUS INFECTION OF HUMAN LYMPHOCYTES-B [J].
ALFIERI, C ;
BIRKENBACH, M ;
KIEFF, E .
VIROLOGY, 1991, 181 (02) :595-608
[2]   FUNCTIONAL DOMAINS OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN EBNA-1 [J].
AMBINDER, RF ;
MULLEN, M ;
CHANG, YN ;
HAYWARD, GS ;
HAYWARD, SD .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1466-1478
[3]  
ARMSTRONG AA, 1992, HISTOPATHOLOGY, V21, P72
[4]   DNA-SEQUENCE AND EXPRESSION OF THE B95-8 EPSTEIN-BARR VIRUS GENOME [J].
BAER, R ;
BANKIER, AT ;
BIGGIN, MD ;
DEININGER, PL ;
FARRELL, PJ ;
GIBSON, TJ ;
HATFULL, G ;
HUDSON, GS ;
SATCHWELL, SC ;
SEGUIN, C ;
TUFFNELL, PS ;
BARRELL, BG .
NATURE, 1984, 310 (5974) :207-211
[5]   EPSTEIN-BARR-VIRUS BHRF1 GENE BUT NOT THE CELLULAR PROTOONCOGENE BCL-2 IS EXPRESSED IN ATAXIA-TELANGIECTASIA LYMPHOBLASTOID LINES [J].
BECKER, Y ;
TABOR, E ;
ASHER, Y .
VIRUS GENES, 1991, 5 (01) :33-45
[6]  
BRUSAMOLINO E, 1989, HAEMATOLOGICA, V74, P605
[7]   OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATE STABILITY IN SUBCELLULAR EXTRACTS, CULTURE MEDIA, SERA AND CEREBROSPINAL-FLUID [J].
CAMPBELL, JM ;
BACON, TA ;
WICKSTROM, E .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1990, 20 (03) :259-267
[8]   EPSTEIN-BARR-VIRUS INDUCES AGGRESSIVE LYMPHOPROLIFERATIVE DISORDERS OF HUMAN B-CELL ORIGIN IN SCID/HU CHIMERIC MICE [J].
CANNON, MJ ;
PISA, P ;
FOX, RI ;
COOPER, NR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1333-1337
[9]  
CHEUNG RK, 1991, J BIOL CHEM, V266, P8667
[10]   THE GROWTH TRANSFORMATION OF HUMAN-B CELLS INVOLVES SUPERINDUCTION OF HSP(70) AND HSP(90) [J].
CHEUNG, RK ;
DOSCH, HM .
VIROLOGY, 1993, 193 (02) :700-708